I agree that this site is using cookies. You can find further informations here.
X
Awad, Mark M
~ 3400  results:
Search for persons X
?
1

Three-year overall survival outcomes and correlative analys..:

Ricciuti, Biagio ; Elkrief, Arielle ; Lin, Jessica...
JTO Clinical and Research Reports.  , 2024
Link: https://doi.org/10.1016/..
 
?
2

Mechanistic patterns and clinical implications of oncogenic..:

Cheong, Taek-Chin ; Jang, Ahram ; Wang, Qi...
Nature Communications.  15 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
3

Additional impact of genetic ancestry over race/ethnicity t..:

Wang, Xinan ; Hou, Kangcheng ; Ricciuti, Biagio...
Human Genetics and Genomics Advances.  5 (2024)  3 - p. 100320 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Biomarker-directed targeted therapy plus durvalumab in adva..:

Besse, Benjamin ; Pons-Tostivint, Elvire ; Park, Keunchil...
Nature Medicine.  30 (2024)  3 - p. 716-729 , 2024
Link: https://doi.org/10.1038/..
 
?
5

Outcomes of Combination Platinum-Doublet Chemotherapy and A..:

Elkrief, Arielle ; Ricciuti, Biagio ; Alessi, Joao V...
The Oncologist.  28 (2023)  11 - p. 978-985 , 2023
Link: https://doi.org/10.1093/..
 
?
6

Brief Report: Safety and Antitumor Activity of Durvalumab P..:

Garon, Edward B. ; Spira, Alexander I. ; Goldberg, Sarah B....
Journal of Thoracic Oncology.  18 (2023)  8 - p. 1094-1102 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Plain language summary of the CheckMate 816 study results: ..:

Forde, Patrick M ; Spicer, Jonathan ; Lu, Shun...
Future Oncology.  19 (2023)  8 - p. 549-557 , 2023
Link: https://doi.org/10.2217/..
 
?
8

Clinical and Molecular Features of Long-term Response to Im..:

Thummalapalli, Rohit ; Ricciuti, Biagio ; Bandlamudi, Chaitanya...
Clinical Cancer Research.  29 (2023)  21 - p. 4408-4418 , 2023
Link: https://doi.org/10.1158/..
 
?
9

Multi-institutional analysis of aneuploidy and outcomes to ..:

Alessi, Joao V ; Price, Adam ; Richards, Allison L...
Journal for ImmunoTherapy of Cancer.  11 (2023)  11 - p. e007618 , 2023
Link: https://doi.org/10.1136/..
 
?
10

Letter to the Editor: Reply to Kus and Aktas:

Alessi, Joao V. ; Awad, Mark M.
Journal of Thoracic Oncology.  18 (2023)  8 - p. e84-e85 , 2023
Link: https://doi.org/10.1016/..
 
?
11

Loss of p53 and mutational heterogeneity drives immune resi..:

Zhu, Mingrui ; Kim, Jiwoong ; Deng, Qing...
Cancer Cell.  41 (2023)  10 - p. 1731-1748.e8 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Advanced non-small-cell lung cancer treated with first-line..:

Nishino, Mizuki ; Wang, Xinan ; Ricciuti, Biagio...
European Radiology.  33 (2023)  10 - p. 7284-7293 , 2023
Link: https://doi.org/10.1007/..
 
?
13

Efficacy of PD-(L)1 blockade monotherapy compared with PD-(..:

Elkrief, Arielle ; Alessi, Joao M Victor ; Ricciuti, Biagio...
Journal for ImmunoTherapy of Cancer.  11 (2023)  7 - p. e006994 , 2023
Link: https://doi.org/10.1136/..
 
?
14

Impact of TMB/PD-L1 expression and pneumonitis on chemoradi..:

Alessi, Joao V. ; Ricciuti, Biagio ; Wang, Xinan...
Nature Communications.  14 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
15

Improved Survival Outcomes in Patients With MET-Dysregulate..:

Wolf, Jürgen ; Souquet, Pierre-Jean ; Goto, Koichi...
Clinical Lung Cancer.  24 (2023)  7 - p. 641-650.e2 , 2023
Link: https://doi.org/10.1016/..
 
1-15